|
|
|
Volumn 2, Issue 2, 2001, Pages 61-64
|
|
Management of the neurogenic bladder
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
CAPSAICIN;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DESMOPRESSIN;
MUSCARINIC RECEPTOR BLOCKING AGENT;
NORTRIPTYLINE;
OXYBUTYNIN;
PROPANTHELINE BROMIDE;
RESINIFERATOXIN;
TOLTERODINE;
BLADDER FUNCTION;
BLADDER SURGERY;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONSTIPATION;
DETRUSOR DYSSYNERGIA;
DEVICE;
DOSE RESPONSE;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG MONITORING;
DRUG POTENCY;
DRUG SAFETY;
ELECTROSTIMULATION THERAPY;
EXERCISE;
HUMAN;
HYPERREFLEXIA;
HYPOSALIVATION;
INDWELLING CATHETER;
INTERMITTENT CATHETERIZATION;
MAGNETIC STIMULATION;
NEBULIZATION;
NERVE STIMULATION;
NEUROGENIC BLADDER;
NEUROMODULATION;
PATIENT CARE;
SHORT SURVEY;
TABLET;
TREATMENT FAILURE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
URINE RETENTION;
URINE VOLUME;
VISUAL IMPAIRMENT;
XEROSTOMIA;
|
|
EID: 0035005589
PISSN: 1466142X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
